Here we have used coimmunoprecipitation experiments, protein turnover and ubiquitination assays, RNA-interference and gene expression analyses to examine the possibility that USP17 acts antagonistically with the F-box protein FBXO25, an E3 ubiquitin ligase previously shown to promote ELK-1 ubiquitination and degradation. activity and promote cell proliferation. Here we have used coimmunoprecipitation experiments, protein turnover and ubiquitination assays, RNA-interference and gene expression analyses to examine the possibility that USP17 acts antagonistically with the F-box protein FBXO25, an E3 ubiquitin ligase previously shown to promote ELK-1 ubiquitination and degradation. Our data confirm that FBXO25 and ELK-1 interact in HEK293T cells and that FBXO25 is active toward Hand1 and HAX1, two of its other candidate substrates. However, our data indicate that FBXO25 neither promotes ubiquitination of ELK-1 nor impacts on its transcriptional activity and suggest that an E3 ubiquitin ligase other than FBXO25 regulates ELK-1 ubiquitination and function. gene is usually disrupted in a patient with intellectual disability and epileptic seizures (20). FBXO25 was recently identified as an E3 ubiquitin ligase that promotes the ubiquitination and degradation of ELK-1 (21, 22). We therefore examined whether FBXO25 could also catalyze the monoubiquitination of ELK-1 and thereby operate in opposition to USP17. Although we confirmed that FBXO25 can interact with ELK-1 in cells, an antagonistic relationship between FBXO25 and USP17 toward ELK-1 was not apparent. Indeed, although FBXO25 activity was confirmed with two other candidate substrates, we were unable to detect ubiquitination of ELK-1 or modulation of its function by FBXO25, as previously reported (22). Results 11-hydroxy-sugiol and conversation ELK-1 is usually a substrate for both mono- and polyubiquitination, and we recently showed that USP17 removes monoubiquitin (mUBQ) from ELK-1 (13, 14). USP17 also removes polyubiquitin chains (pUBQ) from ELK-1 (observe below), implying an antagonistic relationship between USP17 and FBXO25, an E3 ubiquitin ligase recently reported to catalyze polyubiquitination of ELK-1 (22). ELK-1 was first identified as 11-hydroxy-sugiol a potential substrate for FBXO25 through interactions (21). Using a V5/His-tagged version of FBXO25, we could detect its conversation with ELK-1 in HEK293T cells [Fig.?1cryptic degron sequences.indicates nonspecific transmission) or overexpressed FBXO25-V5 were detected using H160 and V5 antibodies respectively. HSP90 was used as loading control. shows densitometric quantification of the results, in which levels of ELK-1 were normalized to HSP90. For all those experiments n?= 3. mRNA variants 1 and 2 (“type”:”entrez-nucleotide”,”attrs”:”text”:”NM_183421″,”term_id”:”1677556805″,”term_text”:”NM_183421″NM_183421 and “type”:”entrez-nucleotide”,”attrs”:”text”:”NM_183420″,”term_id”:”1677500989″,”term_text”:”NM_183420″NM_183420), as well as a mutant version lacking the F-box domain name (amino acids 228C266; F) that cannot interact with SKP1 or other components of the SCF1 complex. Consistent with the results obtained using FBXO25-V5, no increase in ELK-pUBQ 11-hydroxy-sugiol was observed upon coexpression of Myc-FBXO25 in HEK293T cells, with or without treatment with MG132 [Fig.?3, and phosphorylation sites T107, S109, and S112 in and were unaffected by FBXO25 expression [Fig.?4, and mRNA were analyzed by qRT-PCR. Levels are offered as fold ratios to (n?= 3). Error bars show SEM. mRNA was analyzed by qRT-PCR. Levels are offered as fold ratios Rabbit Polyclonal to BCLAF1 to (n?= 3). Error bars show SEM. HEK293T cells were reported to express endogenous FBXO25, for which several isoforms exist (25). We first confirmed expression of FBXO25 isoforms (3% of ectopic FBXO25 expression) [Fig.?5and mRNA levels [Fig.?5and mRNA levels [Fig.?5and mRNA were analyzed by qRT-PCR. Levels are offered as fold ratios to (n?= 4). Error bars show SEM. and mRNA were analyzed by qRT-PCR. Levels are offered as fold ratios to (n?= 4; ?or in cells, should not be considered a reliable basis for inferring productive, functional associations. We conclude that this E3 ubiquitin ligase with an important role in limiting ELK-1 activity during cell proliferation and vertebrate development remains to be identified. Experimental procedures Cell culture and extract preparation HEK293T and HeLa cells were produced in Dulbeccos Modified Eagles Medium (DMEM) supplemented with 10% fetal calf serum (FCS), 2?mM?calcium phosphate/DNA coprecipitation. HeLa cells were transfected with TransIT-LT1 reagent (Mirus Bio); MEFs were transfected using the K2 transfection system (Biontex). Coimmunoprecipitations Experiments were performed essentially as explained previously (26). Cells were lysed in co-IP buffer made up of 25?mM Tris HCl pH 7.5, 150?mM KCl, 10?mM NaF, 1?mM Na3VO4, 1% NP-40, supplemented with mammalian protease and phosphatase inhibitor cocktails (Sigma Aldrich) for 1?h at 4 C, and cleared by centrifugation. Lysates were normalized for protein concentration, precleared with protein G sepharose beads and immune complexes were allowed to form over night at 4 C on a rotating wheel. Antibodies used are outlined in Supplementary Information. Immune complexes were collected on protein G Sepharose beads by centrifugation, washed five occasions in co-IP buffer, and released 11-hydroxy-sugiol by boiling in SDS gel-loading buffer. Ubiquitination assays Cells were lysed in buffer.